New HPA Guidance Includes DIFICLIR™ (fidaxomicin) To Curb Clostridium Difficile infection

New antibiotic treatment recommended for all recurrent cases of potentially fatal hospital-acquired infection The Department of Health (DH) and Health Protection Agency (HPA) (Public Health England) have issued new best practice guidance recommending fidaxomicin, a first-in-class antibiotic for Clostridium difficile infection (CDI) for the treatment of CDI in adults with CDI recurrence and/or with severe cases of the infection who are considered at high risk for recurrence (elderly patients with multiple comorbidities who are receiving concomitant antibiotics)...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news